Recognizing the urgency of the situation for the global advocacy community, Bristol Myers Squibb and GRYT Health have launched the COVID Advocacy Exchange, a virtual platform to unite advocacy organizations, patients and industry in the exchange of information.

The global spread of COVID-19 is affecting each of us and the communities in which we live in different ways, and we recognize this is a challenging time for everyone.  As part of our continued commitment to patients worldwide, we have been in ongoing communication with the global patient advocacy community across disease areas – including oncology, cardiovascular, immunology and fibrosis, hematology and multiple sclerosis – to understand how they are being impacted by the current crisis, and what resources they most need in order to continue to fulfill their missions.

Across the board, we have heard from advocates that their biggest concerns are time and capacity constraints, infrastructure needs, and the lasting financial impact from the current crisis.  This new, entirely virtual platform convenes advocacy groups to synchronize their efforts, facilitate resource sharing with each other and with patients and affiliates, and provide an opportunity for increased collaboration, both now and over the long-term.